CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Previously Reported	Revision of Prior Period, Reclassification, Adjustment	Common Stock	Common Stock Previously Reported	Common Stock Revision of Prior Period, Reclassification, Adjustment	Treasury Stock	Treasury Stock Previously Reported	Treasury Stock Revision of Prior Period, Reclassification, Adjustment	Additional Paid-in Capital	Additional Paid-in Capital Previously Reported	Additional Paid-in Capital Revision of Prior Period, Reclassification, Adjustment	Accumulated Deficit	Accumulated Deficit Previously Reported
Convertible Redeemable Preferred stock, beginning balance (in shares) at Mar. 31, 2021	7,752,515	7,752,515
Convertible Redeemable Preferred Stock, beginning balance at Mar. 31, 2021	$ 59,987	$ 59,987
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of Preferred Shares (in shares)	(7,752,515)
Conversion of Preferred Shares	$ (59,987)
Convertible Redeemable Preferred Stock, ending balance (in shares) at Dec. 31, 2021	0
Convertible Redeemable Preferred Stock, ending balance at Dec. 31, 2021	$ 0
Shares outstanding, beginning balance (in shares) at Mar. 31, 2021				48,071,777	5,498,588	42,573,189	0	259,953	(259,953)
Beginning balance at Mar. 31, 2021	(158,970)	$ (158,970)	$ 0	$ 0	$ 0		$ 0	$ (4,764)	$ 4,764	$ 20,984	$ 25,748	$ (4,764)	$ (179,954)	$ (179,954)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(31,589)												(31,589)
Issuance for stock options exercised (in shares)				5,508,181
Issuance for stock options exercised	2,829									2,829
Issuance for warrants exercised (in shares)				1,931,621
Issuance for warrants exercised	1,019									1,019
Issuance for common stock vested (in shares)				20,000,000
Issuance for common stock vested	200,000									200,000
Restricted shares vesting (in shares)				7,124
Restricted shares vesting	0
Stock-based compensation	11,036									11,036
Conversion of Preferred Shares (in shares)				7,752,515
Conversion of Preferred Shares	59,987									59,987
Conversion of Convertible Notes (in shares)				1,135,713
Conversion of Convertible Notes	12,128									12,128
Net equity infusion from the Merger (in shares)				89,088,942
Net equity infusion from the Merger	150,257			$ 1						150,256
Cumulative translation adjustment	1												1
Shares outstanding, ending balance (in shares) at Dec. 31, 2021				173,495,873			0
Ending balance at Dec. 31, 2021	$ 246,698			$ 1			$ 0			458,239			(211,542)
Convertible Redeemable Preferred Stock, ending balance (in shares) at Dec. 31, 2021	0
Convertible Redeemable Preferred Stock, ending balance at Dec. 31, 2021	$ 0
Shares outstanding, beginning balance (in shares) at Sep. 30, 2021				171,069,553
Beginning balance at Sep. 30, 2021	253,879			$ 1						452,180			(198,302)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(13,241)												(13,241)
Issuance for stock options exercised (in shares)				2,426,047
Issuance for stock options exercised	1,698									1,698
Restricted shares vesting (in shares)				273
Restricted shares vesting	0
Stock-based compensation	4,209									4,209
Conversion of Convertible Notes	152									152
Cumulative translation adjustment	1												1
Shares outstanding, ending balance (in shares) at Dec. 31, 2021				173,495,873			0
Ending balance at Dec. 31, 2021	$ 246,698			$ 1			$ 0			458,239			(211,542)
Shares outstanding, beginning balance (in shares) at Mar. 31, 2022	175,290,143			175,290,143
Beginning balance at Mar. 31, 2022	$ 217,061			$ 1						465,313			(248,253)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(47,317)												(47,317)
Issuance for stock options exercised (in shares)				1,551,831
Issuance for stock options exercised	980									980
Issuance for common stock vested (in shares)				991,315
Issuance for common stock vested	0
Issuance of common stock in connection with the employee stock purchase plan (in shares)				109,186
Issuance of common stock in connection with the employee stock purchase plan	145									145
Common stock withheld for tax upon release (in shares)				(305,749)
Common stock withheld for tax upon release	(649)									(649)
Stock-based compensation	11,876									11,876
Cumulative translation adjustment	$ (18)												(18)
Shares outstanding, ending balance (in shares) at Dec. 31, 2022	177,636,726			177,636,726
Ending balance at Dec. 31, 2022	$ 182,078			$ 1						477,665			(295,588)
Shares outstanding, beginning balance (in shares) at Sep. 30, 2022				177,101,991
Beginning balance at Sep. 30, 2022	200,107			$ 1						474,404			(274,298)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(21,270)												(21,270)
Issuance for stock options exercised (in shares)				86,455
Issuance for stock options exercised	84									84
Issuance for common stock vested (in shares)				491,221
Issuance for common stock vested	0
Issuance of common stock in connection with the employee stock purchase plan (in shares)				109,186
Issuance of common stock in connection with the employee stock purchase plan	145									145
Common stock withheld for tax upon release (in shares)				(152,127)
Common stock withheld for tax upon release	(649)									(649)
Stock-based compensation	3,681									3,681
Cumulative translation adjustment	$ (20)												(20)
Shares outstanding, ending balance (in shares) at Dec. 31, 2022	177,636,726			177,636,726
Ending balance at Dec. 31, 2022	$ 182,078			$ 1						$ 477,665			$ (295,588)